CareLit · DOI-Nachweis · Senologie - Zeitschrift für Mammadiagnostik und -therapie
Effectiveness outcomes by treatment-free interval among patients receiving palbociclib plus endocrine therapy in HR+/HER2- advanced breast cancer in the real- world setting: Results from the PERFORM study
DOI 10.1055/s-0046-1819802
Bibliografische Angaben
Nachweis in CareLit
Autor:innenJ Radosa, R Bartsch, M Korell, G Pfeiler, T Gabrysiak, T Fietz, M Deryal, V Petersen, T Resch, B Schöttker, T Decker, L Müller, U Rhein, M Glasstetter, U Oppermann, L Floren, A Wegenast, B Sauer, A Buder, M P Lux
ZeitschriftSenologie - Zeitschrift für Mammadiagnostik und -therapie
Ausgabe02/2026
Jahrgang / SeitenJg. 23 · S. e30-e31
Kernaussage aus der Literatur
Abstract-Vorschau
Effectiveness outcomes by treatment-free interval among patients receiving palbociclib plus endocrine therapy in HR+/HER2- advanced breast cancer in the real- world setting: Results from the PERFORM study
Zitieren
Zitierempfehlung
J Radosa, R Bartsch, M Korell, G Pfeiler, T Gabrysiak, T Fietz, M Deryal, V Petersen, T Resch, B Schöttker, T Decker, L Müller, U Rhein, M Glasstetter, U Oppermann, L Floren, A Wegenast, B Sauer, A Buder, M P Lux (2026) Effectiveness outcomes by treatment-free interval among patients receiving palbociclib plus endocrine therapy in HR+/HER2- advanced breast cancer in the real- world setting: Results from the PERFORM study. Senologie - Zeitschrift für Mammadiagnostik und -therapie, 23 (02), e30-e31. https://doi.org/10.1055/s-0046-1819802
Mit CareLit weiterarbeiten